Literature DB >> 9259467

Antiproliferative activity of KCl contributes to EGF-induced neurite outgrowth in PC12 cells.

M D Mark1, D R Storm.   

Abstract

Combinations of epidermal growth factor (EGF) and KCl stimulate differentiation in PC12 cells, independent of extracellular calcium [Mark et al., Stimulation of neurite outgrowth in PC12 cells by EGF and KCl depolarization: a Ca2+-independent phenomenon, J. Cell Biol., 130 (1995) 701-710]. Since EGF is a proliferative agent that normally does not stimulate differentiation of PC12 cells, we hypothesize that KCl plus EGF may cause differentiation because of the anti-proliferative activity of KCl. Here we report that treatment of PC12 cells with KCl plus EGF resulted in a significant decrease in proliferation and DNA synthesis compared with cells treated with EGF alone. In addition, KCl significantly reduced the EGF-induced expression of cell cycle progression factors cdk2, cdk4, cyclin B1 and PCNA. These data suggest that the anti-proliferative activity of KCl may convert EGF from a proliferative factor to a progression factor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259467     DOI: 10.1016/s0304-3940(97)00491-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Claulansine F promotes neuritogenesis in PC12 cells via the ERK signaling pathway.

Authors:  Yin-zhong Ma; Na Ning; Wen-bin He; Jing-wei Li; Jin-feng Hu; Shi-feng Chu; Nai-hong Chen
Journal:  Acta Pharmacol Sin       Date:  2013-10-07       Impact factor: 6.150

2.  The ret-Activating Ligand GDNF Is Differentiative and Not Mitogenic for Normal and Neoplastic Human Chromaffin Cells In Vitro.

Authors:  James F. Powers; Panayiotis Tsokas; Arthur S. Tischler
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

3.  KCC2 expression supersedes NKCC1 in mature fiber cells in mouse and rabbit lenses.

Authors:  Peter H Frederikse; Chinnaswamy Kasinathan
Journal:  Mol Vis       Date:  2015-10-13       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.